Mycosis Fungoides Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: MFDB1A057BB3EN
Market Monitor Global

Abstracts

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and there is an increase in its incidence of mycosis fungoides.

This report contains market size and forecasts of Mycosis Fungoides Therapeutics in Global, including the following market information:

Global Mycosis Fungoides Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mycosis Fungoides Therapeutics market was valued at 554.1 million in 2021 and is projected to reach US$ 738.6 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Small Molecules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mycosis Fungoides Therapeutics include Azurity Pharmaceuticals Inc., Celgene Corp., Eisai Co. Ltd., Helsinn Healthcare SA, Horizon Therapeutics Plc, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Seattle Genetics Inc. and Soligenix Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mycosis Fungoides Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mycosis Fungoides Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mycosis Fungoides Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Small Molecules
• Biologics

Global Mycosis Fungoides Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mycosis Fungoides Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Mycosis Fungoides Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mycosis Fungoides Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mycosis Fungoides Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mycosis Fungoides Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Azurity Pharmaceuticals Inc.
• Celgene Corp.
• Eisai Co. Ltd.
• Helsinn Healthcare SA
• Horizon Therapeutics Plc
• Kyowa Kirin Co. Ltd.
• Merck & Co. Inc.
• Seattle Genetics Inc.
• Soligenix Inc.
• Takeda Pharmaceutical Co. Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mycosis Fungoides Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mycosis Fungoides Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYCOSIS FUNGOIDES THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Mycosis Fungoides Therapeutics Market Size: 2021 VS 2028
2.2 Global Mycosis Fungoides Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mycosis Fungoides Therapeutics Players in Global Market
3.2 Top Global Mycosis Fungoides Therapeutics Companies Ranked by Revenue
3.3 Global Mycosis Fungoides Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Mycosis Fungoides Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mycosis Fungoides Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mycosis Fungoides Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Mycosis Fungoides Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mycosis Fungoides Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mycosis Fungoides Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Small Molecules
  4.1.3 Biologics
4.2 By Type - Global Mycosis Fungoides Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Mycosis Fungoides Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Mycosis Fungoides Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mycosis Fungoides Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Mycosis Fungoides Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Mycosis Fungoides Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Mycosis Fungoides Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mycosis Fungoides Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Mycosis Fungoides Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Mycosis Fungoides Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Mycosis Fungoides Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mycosis Fungoides Therapeutics Revenue, 2017-2028
  6.3.2 US Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.3.3 Canada Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Mycosis Fungoides Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mycosis Fungoides Therapeutics Revenue, 2017-2028
  6.4.2 Germany Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.3 France Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.5 Italy Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.6 Russia Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Mycosis Fungoides Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mycosis Fungoides Therapeutics Revenue, 2017-2028
  6.5.2 China Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.5.3 Japan Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.5.6 India Mycosis Fungoides Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mycosis Fungoides Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Mycosis Fungoides Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mycosis Fungoides Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.7.3 Israel Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Mycosis Fungoides Therapeutics Market Size, 2017-2028
  6.7.5 UAE Mycosis Fungoides Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Azurity Pharmaceuticals Inc.
  7.1.1 Azurity Pharmaceuticals Inc. Corporate Summary
  7.1.2 Azurity Pharmaceuticals Inc. Business Overview
  7.1.3 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Major Product Offerings
  7.1.4 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Azurity Pharmaceuticals Inc. Key News
7.2 Celgene Corp.
  7.2.1 Celgene Corp. Corporate Summary
  7.2.2 Celgene Corp. Business Overview
  7.2.3 Celgene Corp. Mycosis Fungoides Therapeutics Major Product Offerings
  7.2.4 Celgene Corp. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Celgene Corp. Key News
7.3 Eisai Co. Ltd.
  7.3.1 Eisai Co. Ltd. Corporate Summary
  7.3.2 Eisai Co. Ltd. Business Overview
  7.3.3 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Major Product Offerings
  7.3.4 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Eisai Co. Ltd. Key News
7.4 Helsinn Healthcare SA
  7.4.1 Helsinn Healthcare SA Corporate Summary
  7.4.2 Helsinn Healthcare SA Business Overview
  7.4.3 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Major Product Offerings
  7.4.4 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Helsinn Healthcare SA Key News
7.5 Horizon Therapeutics Plc
  7.5.1 Horizon Therapeutics Plc Corporate Summary
  7.5.2 Horizon Therapeutics Plc Business Overview
  7.5.3 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Major Product Offerings
  7.5.4 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Horizon Therapeutics Plc Key News
7.6 Kyowa Kirin Co. Ltd.
  7.6.1 Kyowa Kirin Co. Ltd. Corporate Summary
  7.6.2 Kyowa Kirin Co. Ltd. Business Overview
  7.6.3 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Major Product Offerings
  7.6.4 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Kyowa Kirin Co. Ltd. Key News
7.7 Merck & Co. Inc.
  7.7.1 Merck & Co. Inc. Corporate Summary
  7.7.2 Merck & Co. Inc. Business Overview
  7.7.3 Merck & Co. Inc. Mycosis Fungoides Therapeutics Major Product Offerings
  7.7.4 Merck & Co. Inc. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Merck & Co. Inc. Key News
7.8 Seattle Genetics Inc.
  7.8.1 Seattle Genetics Inc. Corporate Summary
  7.8.2 Seattle Genetics Inc. Business Overview
  7.8.3 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Major Product Offerings
  7.8.4 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Seattle Genetics Inc. Key News
7.9 Soligenix Inc.
  7.9.1 Soligenix Inc. Corporate Summary
  7.9.2 Soligenix Inc. Business Overview
  7.9.3 Soligenix Inc. Mycosis Fungoides Therapeutics Major Product Offerings
  7.9.4 Soligenix Inc. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Soligenix Inc. Key News
7.10 Takeda Pharmaceutical Co. Ltd.
  7.10.1 Takeda Pharmaceutical Co. Ltd. Corporate Summary
  7.10.2 Takeda Pharmaceutical Co. Ltd. Business Overview
  7.10.3 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Major Product Offerings
  7.10.4 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Takeda Pharmaceutical Co. Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mycosis Fungoides Therapeutics Market Opportunities & Trends in Global Market
Table 2. Mycosis Fungoides Therapeutics Market Drivers in Global Market
Table 3. Mycosis Fungoides Therapeutics Market Restraints in Global Market
Table 4. Key Players of Mycosis Fungoides Therapeutics in Global Market
Table 5. Top Mycosis Fungoides Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mycosis Fungoides Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mycosis Fungoides Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mycosis Fungoides Therapeutics Product Type
Table 9. List of Global Tier 1 Mycosis Fungoides Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mycosis Fungoides Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mycosis Fungoides Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mycosis Fungoides Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mycosis Fungoides Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mycosis Fungoides Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mycosis Fungoides Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mycosis Fungoides Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Azurity Pharmaceuticals Inc. Corporate Summary
Table 31. Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Product Offerings
Table 32. Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corp. Corporate Summary
Table 34. Celgene Corp. Mycosis Fungoides Therapeutics Product Offerings
Table 35. Celgene Corp. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Eisai Co. Ltd. Corporate Summary
Table 37. Eisai Co. Ltd. Mycosis Fungoides Therapeutics Product Offerings
Table 38. Eisai Co. Ltd. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Helsinn Healthcare SA Corporate Summary
Table 40. Helsinn Healthcare SA Mycosis Fungoides Therapeutics Product Offerings
Table 41. Helsinn Healthcare SA Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Horizon Therapeutics Plc Corporate Summary
Table 43. Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Product Offerings
Table 44. Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Kyowa Kirin Co. Ltd. Corporate Summary
Table 46. Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Product Offerings
Table 47. Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co. Inc. Corporate Summary
Table 49. Merck & Co. Inc. Mycosis Fungoides Therapeutics Product Offerings
Table 50. Merck & Co. Inc. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Seattle Genetics Inc. Corporate Summary
Table 52. Seattle Genetics Inc. Mycosis Fungoides Therapeutics Product Offerings
Table 53. Seattle Genetics Inc. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Soligenix Inc. Corporate Summary
Table 55. Soligenix Inc. Mycosis Fungoides Therapeutics Product Offerings
Table 56. Soligenix Inc. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Pharmaceutical Co. Ltd. Corporate Summary
Table 58. Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Product Offerings
Table 59. Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mycosis Fungoides Therapeutics Segment by Type in 2021
Figure 2. Mycosis Fungoides Therapeutics Segment by Application in 2021
Figure 3. Global Mycosis Fungoides Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mycosis Fungoides Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mycosis Fungoides Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mycosis Fungoides Therapeutics Revenue in 2021
Figure 8. By Type - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mycosis Fungoides Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mycosis Fungoides Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Corp. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eisai Co. Ltd. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Helsinn Healthcare SA Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co. Inc. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Seattle Genetics Inc. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Soligenix Inc. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)